Board Increases Dividend, Authorizes New Share Repurchase, Names Garrett
Chairman
FULLERTON, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Beckman Coulter,
Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of
products that simplify, automate and innovate complex biomedical testing,
announced today fourth quarter and year ended December 31, 2007 results.
For the fourth quarter, revenue was $789 million, rising on strong sales to
clinical diagnostics customers partially offset by softness in demand for
life science products. In constant currency, revenue increased 6.8%.
Reported net earnings were $44.8 million, or $0.69 per fully diluted share.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)
Quarter Ended Year Ended
December 31 December 31
2007 2006 % Chg 2007 2006 % Chg
Reported Results
(in millions)
Revenue $789.0 $712.0 10.8% $2,761.3 $2,528.5 9.2%
Earnings per
Diluted Share:
Continuing
Operations $0.69 $0.97 (28.9%) $3.27 $2.47 32.4%
Discontinued
Operations - - - 0.03 0.45 (93.3%)
Net $0.69 $0.97 (28.9%) $3.30 $2.92 13.0%
Adjusted Results
Excluding Special Items
Earnings per
Diluted Share $1.08 $1.03 4.9% $3.25 $2.88 12.8%
See "Non-GAAP Financial Measures," where the impacts of certain items
on reported results are d
'/>"/>
| SOURCE Beckman Coulter, Inc. Copyright©2008 PR Newswire. All rights reserved |